Valsartan Recall Lawsuits.
Prescribed drugs used for the treatment of high blood pressure and heart failure with confirmed high levels of NDMA (nitrosodimethylamine) and NDEA (Nitrosodiethylamine) from valsartan are being recalled. The FDA researched valsartan and other ARBs (angiotensin II receptor blockers) and found impurities exceeding acceptable limits. As a result, allegations have been made against generic drug companies, stating that some of these companies have known about the issue since 2012 but have done nothing to prevent the problems.
What Valsartan is and What Purpose it Serves
Valsartan is an angiotensin II receptor antagonist intended to relax blood vessels and help blood flow smoothly. This common drug is just one of the means to an end for preventing strokes, heart attacks, kidney problems and more.
Side-Effects and Results
While there are some side-effects like dizziness and lightheadedness that can come with taking medications with valsartan, there are much more serious results. As mentioned before, valsartan products with high levels of NDMA and NDEA are being recalled, and that is because these chemicals increase the users chance of getting cancer. Recently, an outbreak of lawsuits involving tainted valsartan drugs have made it to courts around the nation for the critical conditions of the plaintiffs. The allegations are stating that medical drugs with valsartan are the cause for the following conditions:
- Colorectal Cancer
- Gastric Cancer
- Kidney Cancer
- Kidney Damage
- Liver Cancer
- Liver Damage
Not everyone that takes medication with valsartan is automatically going to end up with cancers or conditions like these, but there is valid data showing reasons to be concerned.
Companies Selling Dangerous Valsartan Dosages
In addition, not all valsartan drugs are contaminated but enough of them are. Here is the FDA’s short list of specific companies reported to be selling products with high dosages of valsartan, and more specifically, high-levels of NDMA or NDEA:
- Aurobindo Pharma Ltd
- Hetero Labs Ltd
- Mylan Pharmaceutical Inc.
- Prinston Pharmaceutical
- Teva Pharmaceuticals
- Torrent Pharmaceuticals
Depending on the product, the dosage of valsartan may be too high. The numbers behind these potentially carcinogenic products are as follows:
- 1 out of 8,000 individuals that take valsartan at the highest dose (320 mg) containing NDMA may end up with cancer.
- 1 out of 18,000 individuals that take valsartan at the highest dose (320 mg) containing NDEA may end up with cancer.
What the Problem is and What You Can Do
The numbers and information are unsettling for sure, however, it isn’t necessarily the active ingredients to fear but the different versions of the drugs. The main problem is that a lot of these generic drugs are poorly produced in overseas labs. In this production, that valsartan comes out tainted or contaminated with high levels of NDMA and NDEA.
What the FDA suggest for those using valsartan in their medicines is to look at the drug name and company name and make sure it isn’t one of the companies with recalled products. However, Unless you have an approved replacement, you should not stop taking your medication. Individuals should contact their health care provider to discuss their treatment and find a different option if their current medication is found on the recall list.
If you or a loved one feels like they have a case with valsartan products, you may be entitled to financial compensation. To review whether or not you have a case, contact one of our experienced attorneys at 801-699-9999 or fill out our form online.